PE anti-human CD8 Antibody
- 产品名称：
- PE anti-human CD8 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 344705
- 产品应用：
- 344705
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1848 |
1 |
- Verified Reactivity
- Human, Cynomolgus, Rhesus
- Reported Reactivity
- African Green, Chimpanzee, Pigtailed Macaque, Sooty Mangabey
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Clone SK1 recognizes the a chain of CD8. Additional reported applications (for the relevant formats) include: proteogenomics8, immunohistochemistry of acetone-fixed frozen tissue sections, and spatial biology (IBEX)9,10.?This clone was tested in-house and does not demonstrate utility for formalin-fixed paraffin-embedded (FFPE) human tonsil sections.
- Application References
(PubMed link indicates BioLegend citation) -
- Ledbetter JA, et al. 1981. J. Exp. Med. 153:310.
- Campanelli R, et al. 2002. Intl. Immunol. 14:39.
- Evans RL, et al. 1981. Immunol. 78:544.
- Wooldridge L, et al. 2005. J. Bio. Chem. 280:27491.
- Ch'el IL, et al. 2011. J Exp Med. 208:633. PubMed
- Carbone A, et al. 1999. Blood 93:2319. (IHC-F)
- Ahmed A, et al. 2001. J. Pathol. 193:383. (IHC)
- Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
- Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
- Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed
- Product Citations
-
- Landry LG, et al. 2021. Bio Protoc. 11:e3883. PubMed
- Zhang H, et al. 2021. Cancer Gene Ther. Online ahead of print. PubMed
- Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
- Crespo ?C, et al. 2020. Cell. 182(5):1125-1139. PubMed
- Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
- Della–Torre E, et al. 2018. Arthritis Rheumatol. 70:1133. PubMed
- Vandooren J, et al. 2021. Front Immunol. 12:701739. PubMed
- Massafra V, et al. 2021. J Immunol. 207:493. PubMed
- Price A, et al. 2016. Proc Natl Acad Sci U S A. 113: 10678 - 1068. PubMed
- Leite NC, et al. 2020. Cell Reports. 32(2):107894.. PubMed
- Meng W,et al. 2017. Antimicrob Agents Chemother.. 10.1128/AAC.01719-17. PubMed
- Wang N, et al. 2021. iScience. 24:103205. PubMed
- Meyer LK, et al. 2019. J Clin Invest. 130:863. PubMed
- Ng CY, et al. 2022. EMBO Rep. 23:e54271. PubMed
- Gimenez-Rivera V, et al. 2016. J Immunol. 197(11):4240-4246. PubMed
- You L, et al. 2020. Front Immunol. 1.699305556. PubMed
- Jing L, et al. 2020. Cancer Immunol Res. 8:648. PubMed
- Zhong G, et al. 2022. Oncoimmunology. 11:2114740. PubMed
- Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
- Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
- Amer HT, et al. 2022. Front Mol Biosci. 9:1032517. PubMed
- Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
- Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
- Chen J, et al. 2021. J Invest Dermatol. 787:141. PubMed
- Winkler C, et al. 2021. JCI Insight. 6:. PubMed
- Ng CY, et al. 2022. EMBO Rep. 23:e55871. PubMed
- Reitinger C, et al. 2022. Front Immunol. 13:970290. PubMed
- Li Q, et al. 2022. J Biol Chem. :101753. PubMed
- Wakeley ME, et al. 2020. J Surg Res. 245:610. PubMed
- Lee IK, et al. 2020. Cancers (Basel). 12:. PubMed
- RRID
- AB_1953243 (BioLegend Cat. No. 344705) AB_1953244 (BioLegend Cat. No. 344706)
- Structure
- Ig superfamily, homodimer or heterodimer with CD8b, 32-34 kD
- Distribution
-
Majority of thymocytes, T cell subset, NK cells
- Function
- MHC class I co-receptor, thymic differentiation, T cell activation
- Ligand/Receptor
- MHC Class I molecules
- Cell Type
- NK cells, T cells, Thymocytes
- Biology Area
- Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Barclay N, et al. 1993. The Leucocyte Antigen FactsBook. Academic Press Inc. San Diego.
- Gene ID
- 925 View all products for this Gene ID
- UniProt
- View information about CD8 on UniProt.org
